Asbestos and the lung in the 21st century: an update

DOI Web Site Web Site 被引用文献6件

書誌事項

公開日
2013-07-31
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1111/crj.12028
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>The asbestos‐related disorders (<jats:styled-content style="fixed-case">ARDs</jats:styled-content>) are currently of significant occupational and public health concern. Asbestos usage has been banned in most developed countries, but asbestos is still used in many developing countries and the number of cases of <jats:styled-content style="fixed-case">ARDs</jats:styled-content> worldwide is rising. Many countries are now experiencing an epidemic of <jats:styled-content style="fixed-case">ARDs</jats:styled-content> that is the legacy of occupational exposure in the 1960s–1980s because of the long latency period between asbestos exposure and manifestation of disease. It is likely that asbestos‐related mortality and morbidity will continue to increase. Although the most feared complications of asbestos inhalation are the malignant conditions such as mesothelioma and lung cancer, asbestos inhalation more frequently results in benign conditions such as pleural plaques, diffuse pleural thickening, and asbestosis (pulmonary fibrosis due to asbestos exposure). Over recent years, there have been changes in the epidemiology of mesothelioma, in clinical management of <jats:styled-content style="fixed-case">ARDs</jats:styled-content> and developments in new techniques for early detection of malignancy. This review provides an update on the respiratory manifestations of asbestos exposure and also considers advances in screening methods that may affect future management in the workplace.</jats:p>

収録刊行物

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ